U.S. Consumer Durables Stock News

Key Insights Significantly high institutional ownership implies Cognyte Software's stock price is sensitive to their...

In November 2025, Ameriprise Financial announced that Houston-based Harpland Financial Management joined its branch channel from Wells Fargo Clearing Services with more than US$160 million in client assets, bringing advisors Peter Horton and Serena Sneeringer and client service associate Micah Horton onto its platform. This move underscores growing adviser interest in Ameriprise’s technology, integrated planning tools, and service support at a time when the firm’s earnings per share,...

Key Insights Institutions' substantial holdings in Gilat Satellite Networks implies that they have significant...

Werner Enterprises (WERN) has been grinding through a tricky freight backdrop, yet the stock has quietly climbed about 12% over the past month and 6% in the past 3 months. See our latest analysis for Werner Enterprises. That recent 7 day share price return of 7.8% and 1 month share price return of 11.8% look more like a relief rally than a full trend change, given the share price is still down year to date and the 1 year total shareholder return sits firmly negative. If Werner’s move has you...

The Morning Bull - US Market Morning Update Tuesday, Dec, 9 2025 US stock futures are edging higher this morning, with S&P 500 contracts up about 0.1 percent, as investors weigh booming global tech demand against rising borrowing costs. Taiwan just reported record November exports of 64 billion US dollars, up 56 percent from a year ago, a sign of powerful demand for chips and electronics that supports US technology and semiconductor names. At the same time, the US 10 year Treasury yield has...

Key Insights Ralliant's estimated fair value is US$54.87 based on 2 Stage Free Cash Flow to Equity With US$51.33 share...

We wouldn't blame Caterpillar Inc. ( NYSE:CAT ) shareholders if they were a little worried about the fact that Andrew...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

The fact that multiple L3Harris Technologies, Inc. ( NYSE:LHX ) insiders offloaded a considerable amount of shares over...

Applied Optoelectronics (AAOI) has been quietly resetting expectations this year, with the stock slipping about 22% year to date even as annual revenue and net income have grown sharply off a low base. See our latest analysis for Applied Optoelectronics. Despite that weak year to date share price return, the stock has quietly rebuilt some momentum, with a 90 day share price return of 17.37% and a striking three year total shareholder return above 1,100% hinting that investors still see...

Kilroy Realty (KRC) shares have slipped over the past month, even as the real estate investment trust continues to generate steady revenue and maintain solid occupancy across its coastal office and life science portfolio. See our latest analysis for Kilroy Realty. At around $40.44, the recent pullback, including a negative 30 day share price return, sits against a modestly positive year to date share price gain and a solid three year total shareholder return. This suggests longer term...

In late 2025, H World Group reported strong Q3 2025 results, marked the opening of its 10,000th hotel, and detailed new expansion plans into Laos through four hotel deals. These milestones highlight how H World Group is using its large-scale network and cross-border growth to reinforce its position in the Asian hotel market. We’ll now explore how the company’s 10,000th hotel milestone and Laos expansion may reshape H World Group’s existing investment narrative. Outshine the giants: these 27...

Janus Henderson Group (NYSE:JHG) has quietly edged higher over the past month, and the move appears to be tied less to headlines and more to a steady improvement in its underlying profitability and returns. See our latest analysis for Janus Henderson Group. At around $44.6 per share, Janus Henderson’s recent gains continue a gradual upward trend, with a 1 year total shareholder return of about 5.5 percent sitting on top of a very strong 3 year total shareholder return of more than 100...

Astronics (ATRO) slipped after Airbus trimmed its 2025 delivery plans, citing fuselage panel quality issues, and the market quickly connected that slowdown to potential demand pressure across the aerospace supply chain. See our latest analysis for Astronics. Even with today’s wobble on the Airbus headline, Astronics’ 1 month share price return of 12.07 percent and year to date share price return of 233.44 percent show strong momentum, supported by a 3 year total shareholder return of 435.06...

ORIC Pharmaceuticals (ORIC) is back in the spotlight after unveiling fresh Phase 1b data for its lung cancer drug enozertinib at ESMO Asia 2025, highlighting systemic and intracranial activity in difficult EGFR and HER2 mutation settings. See our latest analysis for ORIC Pharmaceuticals. The string of upbeat enozertinib updates, analyst support and recent conference exposure comes against a choppy tape, with a weaker 1 month share price return but still a strong year to date share price gain...

Nurix Therapeutics has reported updated Phase 1a/1b data for its BTK degrader bexobrutideg (NX-5948) in relapsed or refractory B‑cell malignancies, including chronic lymphocytic leukemia, with results presented at the 2025 ASH Annual Meeting and supporting 600 mg as the recommended Phase 2 dose. The new data, generated under FDA initiatives Project Optimus and Project Prime, underpin the pivotal DAYBreak Phase 2 program and highlight Nurix’s effort to position BTK degradation as a potential...

In December 2025, Masimo entered into a new unsecured credit facility comprising a US$250 million term loan and US$750 million revolving commitments, replacing its prior agreement and extending maturities to December 2030. The facility’s leverage-linked interest spreads, unused fee, and potential US$400 million accordion highlight how Masimo is reconfiguring its balance sheet to enhance financial flexibility for capital investment and working capital. We’ll now examine how Masimo’s expanded...

Artivion (AORT) has quietly become a strong performer, with shares up sharply this year even after a recent pullback. Investors are starting to weigh whether the current price still reflects its growth trajectory. See our latest analysis for Artivion. The stock’s latest pullback, including a modest 1 day share price return of minus 1.17 percent to 44.07 dollars, comes after a powerful year to date share price return of 56.94 percent and a standout 3 year total shareholder return of 240.84...

National Health Investors (NHI) has quietly outperformed many income names this year, and with its shares up about 15% year to date, investors are asking whether the momentum still matches the fundamentals. See our latest analysis for National Health Investors. The steady year to date share price return of around 15% to about $78.82, backed by solid recent revenue and net income growth, suggests momentum is still building rather than fading, and the market is slowly repricing National Health...

Service Corporation International (SCI) just gave investors a confidence boost, combining upbeat analyst commentary with stronger than expected third quarter results and a higher quarterly dividend that underlines management’s comfort with future cash flows. See our latest analysis for Service Corporation International. The upbeat earnings surprise and dividend hike help explain why, despite a recent 1 month share price return of negative 4.29 percent and a 1 year total shareholder return of...

CACI International (CACI) just landed two sizable multi year task orders with the U.S. Navy and Army, bolstering its backlog and strengthening already important defense relationships that support the stock’s longer term earnings power. See our latest analysis for CACI International. Those fresh Navy and Army wins come after a strong run, with the share price up sharply on a 90 day basis and multi year total shareholder returns showing steady, compounding momentum. If contract driven growth...

In early December 2025, United Natural Foods reported first-quarter sales of US$7.84 billion, a reduced net loss of US$4 million, and US$10 million in long-lived asset impairment charges, while affirming full-year guidance that includes the possibility of returning to a modest profit. Although revenue edged slightly lower year over year, the significantly smaller loss per share and maintained outlook suggest operational progress despite ongoing cost and asset challenges. We’ll now examine...

In early December 2025, Prologis’ Board declared a regular quarterly cash dividend of US$1.01 per common share and a US$1.0675 dividend on its 8.54% Series Q Cumulative Redeemable Preferred Stock, both payable on December 31, 2025, to holders of record on December 16, 2025. Alongside record leasing of nearly 62 million square feet, a growing data center pipeline, and raised operational guidance, these dividends underline how Prologis is leaning on both stable cash returns and expanding...

In recent days, Standex International was upgraded to a “buy” rating by Wall Street Zen and other analysts after the company posted earnings that exceeded estimates and delivered strong year-on-year revenue growth. This combination of analyst optimism and outperformance against expectations points to rising confidence in Standex’s execution and demand for its products across key end markets. We’ll now examine how the recent analyst upgrades, following Standex’s earnings beat, may influence...